Cargando…
Use of Botulinum Toxin in Treating Rosacea: A Systematic Review
BACKGROUND: Rosacea is a chronic skin disorder characterized by erythema, flushing, telangiectasia, papules and pustules, phymatous changes, and ocular involvement. The aim of this study was to examine all published research articles in which botulinum toxin was used to treat rosacea and to evaluate...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096341/ https://www.ncbi.nlm.nih.gov/pubmed/33958886 http://dx.doi.org/10.2147/CCID.S307013 |
_version_ | 1783688141692993536 |
---|---|
author | Zhang, Hanlin Tang, Keyun Wang, Yuanzhuo Fang, Rouyu Sun, Qiuning |
author_facet | Zhang, Hanlin Tang, Keyun Wang, Yuanzhuo Fang, Rouyu Sun, Qiuning |
author_sort | Zhang, Hanlin |
collection | PubMed |
description | BACKGROUND: Rosacea is a chronic skin disorder characterized by erythema, flushing, telangiectasia, papules and pustules, phymatous changes, and ocular involvement. The aim of this study was to examine all published research articles in which botulinum toxin was used to treat rosacea and to evaluate the efficacy and safety of this treatment. METHODS: PubMed, Embase, Cochrane Library, and Web of Science database were used to identify articles eligible for systematic review on March 26, 2021. Prospective or retrospective studies which directly used botulinum toxin to treat rosacea were included and reviewed. RESULTS: Nine studies were included in this systematic review. Two were randomized controlled trials, graded as Level 2 for the quality of evidence. The total number of participants was 130, and the number of participants in each study ranged from 1 to 25. The improvement was observed in all studies in signs and symptoms compared with baseline. Adverse events were transitory and self-limited. CONCLUSION: Botulinum toxin could have overall satisfying efficacy and safety in the treatment of rosacea, though limited by small sample size, imperfect study design, and short follow-up visits. |
format | Online Article Text |
id | pubmed-8096341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-80963412021-05-05 Use of Botulinum Toxin in Treating Rosacea: A Systematic Review Zhang, Hanlin Tang, Keyun Wang, Yuanzhuo Fang, Rouyu Sun, Qiuning Clin Cosmet Investig Dermatol Original Research BACKGROUND: Rosacea is a chronic skin disorder characterized by erythema, flushing, telangiectasia, papules and pustules, phymatous changes, and ocular involvement. The aim of this study was to examine all published research articles in which botulinum toxin was used to treat rosacea and to evaluate the efficacy and safety of this treatment. METHODS: PubMed, Embase, Cochrane Library, and Web of Science database were used to identify articles eligible for systematic review on March 26, 2021. Prospective or retrospective studies which directly used botulinum toxin to treat rosacea were included and reviewed. RESULTS: Nine studies were included in this systematic review. Two were randomized controlled trials, graded as Level 2 for the quality of evidence. The total number of participants was 130, and the number of participants in each study ranged from 1 to 25. The improvement was observed in all studies in signs and symptoms compared with baseline. Adverse events were transitory and self-limited. CONCLUSION: Botulinum toxin could have overall satisfying efficacy and safety in the treatment of rosacea, though limited by small sample size, imperfect study design, and short follow-up visits. Dove 2021-04-30 /pmc/articles/PMC8096341/ /pubmed/33958886 http://dx.doi.org/10.2147/CCID.S307013 Text en © 2021 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhang, Hanlin Tang, Keyun Wang, Yuanzhuo Fang, Rouyu Sun, Qiuning Use of Botulinum Toxin in Treating Rosacea: A Systematic Review |
title | Use of Botulinum Toxin in Treating Rosacea: A Systematic Review |
title_full | Use of Botulinum Toxin in Treating Rosacea: A Systematic Review |
title_fullStr | Use of Botulinum Toxin in Treating Rosacea: A Systematic Review |
title_full_unstemmed | Use of Botulinum Toxin in Treating Rosacea: A Systematic Review |
title_short | Use of Botulinum Toxin in Treating Rosacea: A Systematic Review |
title_sort | use of botulinum toxin in treating rosacea: a systematic review |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096341/ https://www.ncbi.nlm.nih.gov/pubmed/33958886 http://dx.doi.org/10.2147/CCID.S307013 |
work_keys_str_mv | AT zhanghanlin useofbotulinumtoxinintreatingrosaceaasystematicreview AT tangkeyun useofbotulinumtoxinintreatingrosaceaasystematicreview AT wangyuanzhuo useofbotulinumtoxinintreatingrosaceaasystematicreview AT fangrouyu useofbotulinumtoxinintreatingrosaceaasystematicreview AT sunqiuning useofbotulinumtoxinintreatingrosaceaasystematicreview |